2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
4
Sponsor Class
OTHER
4
Study Type
Observational
3
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
3
Genitourinary
1
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
11
Osteoporosis
6
Neoplasms
4
Melanoma
3
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Cardiovascular Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Wilms Tumor
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Sarcoma, Ewing
1
Regional Osteoporosis as a Result of Chemotherapy
1
Recurrence
1
Primary Ovarian Insufficiency
1
Polycystic Ovary Syndrome
1
Paraganglioma, Extra-Adrenal
1
Pain
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
pembrolizumab
185
Gemcitabine
170
Paclitaxel
152
Carboplatin
137
Bevacizumab
128
Surveys and Questionnaires
118
Cisplatin
115
Docetaxel
114
Blood Specimen Collection
110
Cyclophosphamide
109
Exercise
108
Nivolumab
98
Fluorouracil
90
Capecitabine
86
Dexamethasone
81
Radiotherapy
80
Irinotecan
74
Standard of Care
69
Pemetrexed
68
Oxaliplatin
68
Leucovorin
64
Drug Therapy
64
Cetuximab
60
Erlotinib Hydrochloride
56
Sorafenib
53
atezolizumab
52
Ipilimumab
51
Doxorubicin
50
trametinib
47
Interviews as Topic
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Neoplasms
×
Absorptiometry, Photon
×
Clear all
NCT03690401
2024-10-28
PostSOZO
Prisma Health-Upstate
Completed
52 enrolled
NCT03784911
2024-10-28
DuringSOZO
Prisma Health-Upstate
Completed
51 enrolled
NCT01641172
2024-04-19
TASTY
University Medical Center Groningen
Phase 4
Completed
140 enrolled
NCT02806154
2023-07-19
FRACTION
University Hospital, Toulouse
Completed
144 enrolled